Author/Creator: Arons, Evgeny - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Arons, Evgeny

1. Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome. (13th June 2014)

Authors:: Arons, Evgeny; Adams, Sharon; Venzon, David J.; Pastan, Ira; Kreitman, Robert J.
Journal:: British journal of haematology
Issue:: Volume 166:Number 5(2014:Sep.)
Page Start:: 729
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. (January 2022)

Authors:: Kreitman, Robert J.; Arons, Evgeny
Journal:: Blood reviews
Issue:: Volume 51(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia. Issue 4 (11th May 2019)

Authors:: Salem, Dalia A.; Scott, Drake; McCoy, Catharine S.; Liewehr, David J.; Venzon, David J.; Arons, Evgeny; Kreitman, Robert J.; Stetler‐Stevenson, Maryalice; Yuan, Constance M.
Journal:: Cytometry
Issue:: Volume 96:Issue 4(2019)
Page Start:: 275
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Generation of antibody-based therapeutics targeting the idiotype of B-cell malignancies. (27th December 2018)

Authors:: Weiss, Emily; Sarnovsky, Robert; Ho, Mitchell; Arons, Evgeny; Kreitman, Robert; Angelus, Evan; Antignani, Antonella; FitzGerald, David
Journal:: Antibody therapeutics
Issue:: Volume 2:Number 1(2019)
Page Start:: 12
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Impact of telomere length on survival in classic and variant hairy cell leukemia. Issue 12 (December 2015)

Authors:: Arons, Evgeny; Zhou, Hong; Edelman, Daniel C.; Gomez, Allison; Steinberg, Seth M.; Petersen, David; Wang, Yonghong; Meltzer, Paul S.; Kreitman, Robert J.
Journal:: Leukemia research
Issue:: Volume 39:Issue 12(2015:Dec.)
Page Start:: 1360
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Melanoma-associated B cells are distinct from peripheral blood-derived B cells, and may serve as a source of tumor-targeting antibodies. (7th November 2013)

Authors:: Abate-Daga, Daniel; Alexander, Theresa A; Arons, Evgeny; Ho, Mitchell; Robbins, Paul F; Rosenberg, Steven A; Morgan, Richard A
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 1(2013)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. The bruton tyrosine kinase inhibitor ibrutinib (PCI‐32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. (2nd April 2014)

Authors:: Sivina, Mariela; Kreitman, Robert J.; Arons, Evgeny; Ravandi, Farhad; Burger, Jan A.
Journal:: British journal of haematology
Issue:: Volume 166:Number 2(2014:Jul.)
Page Start:: 177
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. The bruton tyrosine kinase inhibitor ibrutinib (PCI‐32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. (2nd April 2014)

Authors:: Sivina, Mariela; Kreitman, Robert J.; Arons, Evgeny; Ravandi, Farhad; Burger, Jan A.
Journal:: British journal of haematology
Issue:: Volume 166:Number 2(2014:Jul.)
Page Start:: 177
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗